PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ali_amanati_1356@yahoo.com.\', \'Pediatrics Department, Division of Intensive Care, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Research Center for Traditional Medicine and History of Medicine, School of Medicine, Shiraz University of Medical Sciences, Zand St., Shiraz, Iran. Molavih@sums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12890-021-01706-0
?:doi
?:hasPublicationType
?:journal
  • BMC pulmonary medicine
is ?:pmid of
?:pmid
?:pmid
  • 34715834
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.373
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of the HScore as a predictor of disease outcome in patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all